About: Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
rdfs:subClassOf
Semantic_Type
  • Pharmacologic Substance
  • Immunologic Factor
Preferred_Name
  • Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
NCI_META_CUI
  • CL388414
PDQ_Open_Trial_Search_ID
  • 619122
PDQ_Closed_Trial_Search_ID
  • 619122
Legacy_Concept_Name
  • Allogeneic_Large_Multivalent_Immunogen_Breast_Cancer_Vaccine
FULL_SYN
  • Allogeneic LMI Breast Cancer VaccineSYNCI
  • Allogeneic Large Multivalent Immunogen Breast Cancer VaccinePTNCI
DEFINITION
  • A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer cell line, with potential immunostimulatory and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen breast cancer vaccine may stimulate a cytotoxic T lymphocyte (CTL) immune response against tumor cells that express the breast cancer cell-specific LMIs.NCI
code
  • C79799
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 78 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software